Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $20.87B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: AMCR stock price vs AMGN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AMGN's multiple
Needs AMGN P/E.
Implied fair value · at AMCR's multiple
Needs AMCR P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: AMCR FY 2026 (ended Jun 30, 2026) · AMGN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 60% equity / 40% debt · EV / Revenue 1.44x · EV / EBITDA 10.71x
Capital structure 80% equity / 20% debt · EV / Revenue 7.79x · EV / EBITDA 20.40x
AMGN carries the larger enterprise value at $286.45B against $33.76B; AMCR trades on the lower EV / Revenue multiple (1.44x vs 7.79x); AMCR on the lower EV / EBITDA (10.71x vs 20.40x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
AMCOR PLC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Amgen Inc. · implied price per share
Bear
$121.60
Base
$161.79
Bull
$216.01
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.19x
6.84x
Net debt / EBITDA
Leverage against operating earnings
4.09x
3.57x
Cash and equivalents
Liquid reserves on the balance sheet
$1.12B
$9.13B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SONOCO PRODUCTS CO
AMCR vs SON
PACKAGING CORP OF AMERICA
AMCR vs PKG
Avery Dennison Corp
AMCR vs AVY
BALL Corp
AMCR vs BALL
INTERNATIONAL PAPER CO /NEW/
AMCR vs IP
CROWN HOLDINGS, INC.
AMCR vs CCK
REGENERON PHARMACEUTICALS, INC.
AMCR vs REGN
BIOGEN INC.
AMCR vs BIIB
VERTEX PHARMACEUTICALS INC / MA
AMCR vs VRTX
Gilead Sciences, Inc.
AMCR vs GILD
Moderna, Inc.
AMCR vs MRNA
Eli Lilly and Company
AMCR vs LLY
$14.00B
$59.20B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
